@phdthesis{Stanke2023,
  author    = {Stanke, Sandra},
  title     = {AC electrokinetic immobilization of influenza viruses and antibodies on nanoelectrode arrays for on-chip immunoassays},
  doi       = {10.25932/publishup-61716},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-617165},
  school      = {Universit{\"a}t Potsdam},
  pages     = {x, 115},
  year      = {2023},
  abstract  = {In the present thesis, AC electrokinetic forces, like dielectrophoresis and AC electroosmosis, were demonstrated as a simple and fast method to functionalize the surface of nanoelectrodes with submicrometer sized biological objects. These nanoelectrodes have a cylindrical shape with a diameter of 500 nm arranged in an array of 6256 electrodes. Due to its medical relevance influenza virus as well as anti-influenza antibodies were chosen as a model organism. Common methods to bring antibodies or proteins to biosensor surfaces are complex and time-consuming. In the present work, it was demonstrated that by applying AC electric fields influenza viruses and antibodies can be immobilized onto the nanoelectrodes within seconds without any prior chemical modification of neither the surface nor the immobilized biological object. The distribution of these immobilized objects is not uniform over the entire array, it exhibits a decreasing gradient from the outer row to the inner ones. Different causes for this gradient have been discussed, such as the vortex-shaped fluid motion above the nanoelectrodes generated by, among others, electrothermal fluid flow. It was demonstrated that parts of the accumulated material are permanently immobilized to the electrodes. This is a unique characteristic of the presented system since in the literature the AC electrokinetic immobilization is almost entirely presented as a method just for temporary immobilization. The spatial distribution of the immobilized viral material or the anti-influenza antibodies at the electrodes was observed by either the combination of fluorescence microscopy and deconvolution or by super-resolution microscopy (STED). On-chip immunoassays were performed to examine the suitability of the functionalized electrodes as a potential affinity-based biosensor. Two approaches were pursued: A) the influenza virus as the bio-receptor or B) the influenza virus as the analyte. Different sources of error were eliminated by ELISA and passivation experiments. Hence, the activity of the immobilized object was inspected by incubation with the analyte. This resulted in the successful detection of anti-influenza antibodies by the immobilized viral material. On the other hand, a detection of influenza virus particles by the immobilized anti-influenza antibodies was not possible. The latter might be due to lost activity or wrong orientation of the antibodies. Thus, further examinations on the activity of by AC electric fields immobilized antibodies should follow. When combined with microfluidics and an electrical read-out system, the functionalized chips possess the potential to serve as a rapid, portable, and cost-effective point-of-care (POC) device. This device can be utilized as a basis for diverse applications in diagnosing and treating influenza, as well as various other pathogens.},
  language  = {en}
}
@phdthesis{Wunderlich2014,
  author    = {Wunderlich, Kai},
  title     = {Entwicklung einer parallelen Mehrkomponentenanalyse von Antigen-Antik{\"o}rper-Reaktionen in der Dopinganalyse},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-76869},
  school      = {Universit{\"a}t Potsdam},
  pages     = {VIII, 130},
  year      = {2014},
  abstract  = {Weltweit streben Anti-Doping Institute danach jene Sportler zu {\"u}berf{\"u}hren, welche sich unerlaubter Mittel oder Methoden bedienen. Die hierf{\"u}r notwendigen Testsysteme werden kontinuierlich weiterentwickelt und neue Methoden aufgrund neuer Wirkstoffe der Pharmaindustrie etabliert. Gegenstand dieser Arbeit war es, eine parallele Mehrkomponentenanalyse auf Basis von Antigen-Antik{\"o}rper Reaktionen zu entwickeln, bei dem es prim{\"a}r um Verringerung des ben{\"o}tigten Probevolumens und der Versuchszeit im Vergleich zu einem Standard Nachweis-Verfahren ging. Neben der Verwendung eines Multiplex Ansatzes und der Mikroarraytechnologie stellten ebenfalls die Genauigkeit aller Messparameter, die Stabilit{\"a}t des Versuchsaufbaus sowie die Performance {\"u}ber einen Einfach-Blind-Ansatz Herausforderungen dar. Die Anforderung an den Multiplex Ansatz, keine falschen Signale trotz {\"a}hnlicher Strukturen zu messen, konnte durch die gezielte Kombination von spezifischen Antik{\"o}rpern realisiert werden. Hierf{\"u}r wurden neben Kreuzreaktivit{\"a}tstests auf dem Mikroarray parallel erfolgreich Western Blot Versuche durchgef{\"u}hrt. Jene Antik{\"o}rper, welche in diesen Versuchen die gesetzten Anforderungen erf{\"u}llten, wurden f{\"u}r das Ermitteln der kleinsten nachweisbaren Konzentration verwendet. {\"U}ber das Optimieren der Versuchsbedingungen konnte unter Verwendung von Tween in der Waschl{\"o}sung sowohl auf Glas als auch auf Kunststoff die Hintergrundfluoreszenz reduziert und somit eine Steigerung des Signal/Hintergrundverh{\"a}ltnisses erreicht werden. In den Versuchen zu Ermittlung der Bestimmungsgrenze wurde f{\"u}r das humane Choriongonadotropin (hCG-i) eine Konzentration von 10 mU/ml, f{\"u}r dessen beta-Untereinheit (hCG-beta) eine Konzentration von 3,6 mU/ml und f{\"u}r das luteinisierende Hormon (LH) eine Konzentration von 10 mU/ml bestimmt. Den ermittelten Wert im Serum f{\"u}r das hCG-i entspricht dem von der Welt-Anti-Dopin-Agentur (WADA) geforderten Wert in Urin von 5 mU/ml. Neben der Ermittlung von Bestimmungsgrenzen wurden diese hinsichtlich auftretender Matrixeffekte in Serum und Blut gemessen. Wie aus den Versuchen zur Ermittlung von Kreuzreaktivit{\"a}ten auf dem Mikroarray zu entnehmen ist, lassen sich das LH, das hCG-i und hCG-β ebenfalls in Serum und Blut messen. Die Durchf{\"u}hrung einer Performance-Analyse {\"u}ber einem Einfach-Blind-Ansatz mit 130 Serum Proben, wurde ebenfalls {\"u}ber dieses System realisiert. Die ausgewerteten Proben wurden anschließend {\"u}ber eine Grenzwertoptimierungskurve analysiert und die diagnostische Spezifit{\"a}t ermittelt. F{\"u}r die Messungen des LH konnte eine Sensitivit{\"a}t und Spezifit{\"a}t von 100\% erreicht werden. Demnach wurden alle negativen und positiven Proben eindeutig interpretiert. F{\"u}r das hCG-β konnte ebenfalls eine Spezifit{\"a}t von 100\% und eine Sensitivit{\"a}t von 97\% erreicht werden. Die hCG-i Proben wurden mit einer Spezifit{\"a}t von 100\% und eine Sensitivit{\"a}t von 97,5\% gemessen. Um den Nachweis zu erbringen, dass dieser Versuchsaufbau {\"u}ber mehrere Wochen stabile Signale bei Vermessen von identischen Proben liefert, wurde ein {\"u}ber zw{\"o}lf Wochen angesetzter Stabilit{\"a}tstest f{\"u}r alle Parameter erfolgreich in Serum und Blut durchgef{\"u}hrt. Zusammenfassend konnte in dieser Arbeit erfolgreich eine Mehrkomponentenanalyse als Multiplex Ansatz auf einem Mikroarray entwickelt werden. Die Durchf{\"u}hrung der Performance-Analyse und des Stabilit{\"a}tstests zeigen bereits die m{\"o}gliche Einsatzf{\"a}higkeit dieses Tests im Kontext einer Dopinganalyse.},
  language  = {de}
}
@article{VoellerHeyne2020,
  author    = {V{\"o}ller, Heinz and Heyne, Karen},
  title     = {Evaluation of the Accuracy of the LumiraDx INR Test Using Patients in Receipt of Phenprocoumon Anticoagulation Therapy},
  series = {Point of care : the journal of near-patient testing \& technology},
  volume    = {19},
  journal   = {Point of care : the journal of near-patient testing \& technology},
  number    = {3},
  publisher = {Lippincott Williams \& Wilkins},
  address   = {Philadelphia},
  issn      = {1533-029X},
  doi       = {10.1097/POC.0000000000000207},
  pages     = {72 -- 76},
  year      = {2020},
  abstract  = {Background: The LumiraDx INR Test is a new point-of-care diagnostic test designed to analyze fingerstick blood samples. The test was assessed in patients receiving phenprocoumon (NCT04074980). Methods: Venous plasma international normalized ratio (INR) was measured using the LumiraDx INR Test. LumiraDx INR Test-ascertained capillary whole blood INR was compared with venous plasma INR measured using the IL ACL Elite Pro and Sysmex CS-5100 reference instruments. Results: A total of 102 patients receiving phenprocoumon were recruited. The INR results from venous plasma and capillary whole blood that were analyzed on the LumiraDx INR Test correlated well with those measured using the IL ACL Elite Pro (plasma: n = 25, r = 0.981; capillary blood: n = 74, r = 0.949) and the Sysmex CS-5100 (n = 73, r = 0.950). Conclusions: The LumiraDx INR Test showed high accuracy in analyzing venous plasma and capillary whole blood from patients receiving phenprocoumon.},
  language  = {en}
}
@misc{KerstingRauschBieretal.2014,
  author    = {Kersting, Sebastian and Rausch, Valentina and Bier, Frank Fabian and von Nickisch-Rosenegk, Markus},
  title     = {Multiplex isothermal solid-phase recombinase polymerase amplification for the specific and fast DNA-based detection of three bacterial pathogens},
  series = {Postprints der Universit{\"a}t Potsdam Mathematisch-Naturwissenschaftliche Reihe},
  journal   = {Postprints der Universit{\"a}t Potsdam Mathematisch-Naturwissenschaftliche Reihe},
  number    = {730},
  issn      = {1866-8372},
  doi       = {10.25932/publishup-43047},
  url       = {http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-430479},
  pages     = {1715 -- 1723},
  year      = {2014},
  abstract  = {We report on the development of an on-chip RPA (recombinase polymerase amplification) with simultaneous multiplex isothermal amplification and detection on a solid surface. The isothermal RPA was applied to amplify specific target sequences from the pathogens Neisseria gonorrhoeae, Salmonella enterica and methicillin-resistant Staphylococcus aureus (MRSA) using genomic DNA. Additionally, a positive plasmid control was established as an internal control. The four targets were amplified simultaneously in a quadruplex reaction. The amplicon is labeled during on-chip RPA by reverse oligonucleotide primers coupled to a fluorophore. Both amplification and spatially resolved signal generation take place on immobilized forward primers bount to expoxy-silanized glass surfaces in a pump-driven hybridization chamber. The combination of microarray technology and sensitive isothermal nucleic acid amplification at 38 °C allows for a multiparameter analysis on a rather small area. The on-chip RPA was characterized in terms of reaction time, sensitivity and inhibitory conditions. A successful enzymatic reaction is completed in <20 min and results in detection limits of 10 colony-forming units for methicillin-resistant Staphylococcus aureus and Salmonella enterica and 100 colony-forming units for Neisseria gonorrhoeae. The results show this method to be useful with respect to point-of-care testing and to enable simplified and miniaturized nucleic acid-based diagnostics.},
  language  = {en}
}